LEUKEMIA

Refine Results:

CME

A 72-year-old African American female with myeloid blast crisis CML

A 62-Year Old Causcasian Man With Chronic Myelogenous Leukemia in Cytogenetic Relapse

This program has expired; CME credits no longer available.

CML Patients Resistant to First-Line Therapies

This program has expired; CME credits no longer available.

News

GSK Gives National Comprehensive Cancer Network $4 Milllion to Fund Academic Scientists Through Its Oncology Research Program

The Pink Sheet Daily, 2010 Aug 9, S Haley

NICE Says Yes to Three Cancer Drugs

Elsevier Global Medical News, 2010 Jul 28, J Smith

Tasigna Beats Sprycel to First-Line CML Punch

The Pink Sheet Daily, 2010 Jul 5, J Merrill

Continuous Infusion Doxorubicin Fails to Diminish Cardiotoxicity in Pediatric ALL

Elsevier Global Medical News, 2010 Jul 1, P Wendling

Allogeneic Transplants After Hyper-CVAD Plus Imatinib Boost Ph+ ALL Survival

Elsevier Global Medical News, 2010 Jun 23, N Osterweil

More News ›

Journal Scans

Reduced-Intensity Versus Conventional Myeloablative Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Lymphoblastic Leukemia: A Retrospective Study From the European Group for Blood and Marrow Transplantation

Blood, 2010 Aug 17, M Mohty, et al

Allogeneic Virus-Specific T Cells With HLA Alloreactivity Do Not Produce GVHD in Human Subjects

Blood, 2010 Aug 13, JJ Melenhorst, et al

Arsenic Trioxide Improves Event-Free and Over-all Survival for Adults With Acute Promyelocytic Leukemia: North American Leukemia Intergroup Study C9710

Blood, 2010 Aug 12, BL Powell, et al

Allogeneic Hematopoietic Cell Transplantation for Hematological Malignancy: Relative Risks and Benefits of Double Umbilical Cord Blood

Blood, 2010 Aug 4, CG Brunstein, et al

Long-Term Prognostic Significance of Early Molecular Response to Imatinib in Newly Diagnosed Chronic Myeloid Leukemia: An Analysis From the International Randomized Study of Interferon Versus STI571 (IRIS)

Blood, 2010 Aug 2, TP Hughes, et al

More Journal Scans ›

Review Articles

Genistein and hematological malignancies

Cancer Lett, 2010 Oct 1, Wang Li, et al

Vanadium in the detection, prevention and treatment of cancer: The in vivo evidence

Cancer Lett, 2010 Aug 1, Anupam Bishayee, et al

Molecular mechanisms underlying tumor dormancy

Cancer Lett, 2010 Aug 1, Nava Almog

Associations of social networks with cancer mortality: A meta-analysis

Crit Rev Oncol Hematol, 2010 Aug 1, Martin Pinquart, et al

Cancer in nonagenarians: Profile, treatments and outcomes

Crit Rev Oncol Hematol, 2010 Aug 1, Martine Extermann, et al

All Journals

Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11)

Cancer Lett, 2010 Oct 1, Susan J. Zunino, et al

Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38−/CD123+ leukemic stem cells by chemotherapy-resistance

Cancer Lett, 2010 Oct 1, Lei Zhi, et al

Heat Shock Protein translocation induced by membrane fluidization increases tumor-cell sensitivity to chemotherapeutic drugs

Cancer Lett, 2010 Oct 1, Nina C. Dempsey, et al

Bcr–Abl-independent mechanism of resistance to imatinib in K562 cells: Induction of cyclooxygenase-2 (COX-2) by histone deacetylases (HDACs)

Leuk Res, 2010 Sept 1, Arunasree M. Kalle, et al

High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia

Leuk Res, 2010 Sept 1, Martin Ebinger, et al

More All Journals ›

Viewpoints

10 Practice Changes I May Make Based on Presentations at ASCO 2009

2009 Jun 17, Jeffrey Kirshner, et al

Casting Oral Cancer Drug Therapy in a Different Light

2009 Apr 28, Lee Schwartzberg, et al

Do the Benefits of Breastfeeding Include Protection Against Cancer?

2009 Apr 23, Dave Portnoy, et al

ADAGIO Imatinib Nonadherence in CML Study: Clinical Implications

2009 Apr 22, Isabel Cunningham, et al

It's Not the Time to Relax About CML

2008 Dec 16, Isabel Cunningham, et al

More Viewpoints ›